CNS Diseases: Headaches/migraines, Psychiatric disorders

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/36

encourage image

There's no tags or description

Looks like no tags are added yet.

37 Terms

1
New cards

What are the 2 types of headaches?

  • Primary headache: The headache is the condition itself

  • Secondary headache: Headache is caused by a separate condition


2
New cards

What are the 4 examples of primary headaches?

  • Migraine headache:

    • With aura: Temporary neurological symptoms occur before or during the headache

    • Without aura: Migraine occurs without these warning symptoms

    • Migraines often cause throbbing pain, nausea, and sensitivity to light or sounds

  • Tension headache: “Hatband” headache

    • Feels like a tight band squeezing around the headache

    • Typically causes pressure or dull pain on both sides of the head

  • Cluster headache:

    • Short-lived

    • One-sided: Pain usually occurs around one eye

    • Associated symptoms: Stuffy nose, tearing, and droopy eyelid on the affected side

  • Hypnic headache:

    • Nighttime headache: Occurs during sleep and wakes the person up

    • Global: Means the headache affects the entire head rather than one specific area

  • Pain caused by inflammation of pain-sensitive areas in and around the neck and head


3
New cards

What are examples of secondary headaches?

  • Can be a warning sign of underlying conditions, including brain tumors, aneurysms, meningitis, neck, or head injuries

  • Typically, they start suddenly and are extremely painful


4
New cards

What is a migraine?

  • An episodic headache

  • Normal sensory inputs are perceived as painful stimuli (allodynia)

    • Smth that shouldn’t hurt, hurts


5
New cards

What is the epidemiology of migraines?

Severe migraine is rated as one of the most disabling chronic disorders worldwide

6
New cards

What two factors lead to altered sensory processing?

Complex genetic predisposition combined with behavioral and environmental factors

7
New cards

Where do migraines occur?

Involves a network of multiple cortical, subcortical, and brainstem regions of the brain

8
New cards

What are the aura and without aura symptoms in migraines?

  • Without Aura: Unilateral and pulsating severe headache lasting 4-72 hrs

  • Without aura: Accompanied by nausea, phonophobia (sensitivity to sound), and photophobia (sensitivity to light)

    • Even tho there are no aura symptoms before or during the headache, the above symptoms still exist

      • Migraine symptoms without the additional neurological aura

  • With aura: Attacks are preceded by transient neurological symptoms → Migraine symptoms + temporary neurological aura

    • Visual: Flashing lights, blind spots

    • Sensory: Numbness, tingling

    • Speech: Difficulty speaking

    • Motor (rare): Muscle weaknesss

  • Auras are most frequently visual but can involve other senses or occasionally cause motor or speech deficits


9
New cards

What are the 4 phases of migraines?

  1. Premonitory (prodromal) symptoms:

  • The body starts showing early warning signs that a migraine may be coming (general warning symptoms)

  • Occurs up to 24 hrs before onset

  • Includes food cravings, unexplained mood changes (depression or euphoria), uncontrollable yawning, fluid retention, or increased urination


  1. Aura phase → Before or during headache

  • Temporary neurological disturbances occur (visual, sensory, motor)


  1. Headache phase → Migraine pain begins

  • Pain generally starts gradually

  • Pain increases in intensity

  • Can involve throbbing, nausea, photophobia, and phonophobia


  1. Postdromal phase → After headache

  • The headache has resolved, but the person doesn't feel completely normal yet

    • Exhaustion or fatigue

    • Confusion or difficulty concentrating

    • Can last up to approx 24 hrs or sometimes longer


10
New cards

What are the 4 symptoms of migraines?

  • Routine physical activity, movement, or even coughing or sneezing can worsen the headache pain

  • Most frequently in the morning, especially upon walking

  • Some people have migraines at predictable times, such as before menstruation or on weekends following a stressful week of work

  • Many people feel exhausted or weak following a migraine but are usually symptom-free between attacks


11
New cards

What are the biological risk factors of migraines?

  • Adult women are affected 3x more than men

  • Genetics: Multifactorial polygenic inheritance

    • Familial hemiplegic migraine: An INHERITED type of migraine w/ aura that includes temporary muscle weakness on ONE SIDE of the body

      • Rare, Mendelian inheritance, mutations in ATP1A2, CACNA1A, SCN1A

    • CACNA1A is also a risk allele

  • Additional risks that may cause migraines:

    • Low blood sugar

    • Depression

    • Anxiety

    • Head trauma

    • Hormonal changes


12
New cards

How do CACNA1A gain-of-function mutations contribute to migraines?

  • CACNA1A is a gene that codes for the α1A subunit of a voltage-gated Ca²⁺ channel (called the P/Q-type calcium channel)

  • Mutations in this gene are associated with familial hemiplegic migraine (FHM1) and some other migraine presentations

  • Different mutations can occur throughout the gene’s coding sequence

  • Pre-synaptic voltage-dependent Ca2+ channel


Normally, the action potential arrives at the presynaptic terminal → voltage-gated Ca2+ channels open → Ca2+ enters the presynaptic neuron → vesicles release neurotransmitters → postsynaptic neuron responds


Mutation in CACNA1A:

  • For many migraine-associated FHM1 mutations, the calcium channel has a gain-of-function mutation → channel becomes easier to activate

  1. The mutated channel can open at a lower level of depolarization

  2. More Ca2+ can enter the presynaptic terminal during signaling

  3. Increased Ca2+ entry promotes more neurotransmitter release, especially glutamate

  4. Glutamate is excitatory, so nearby neurons become more easily activated

  5. This increased excitability can promote cortical spreading depression, which is associated with migraine aura


13
New cards

What are two ways CACNA1A mutations can increase neurotransmitter release?

  1. Increase number of Ca2+ channels: Activate the same voltage, same amount of Ca2+ flows in through each channel (no change in depolarization)

  2. Increase sensitivity of channel: Activate at a lower voltage/depolarization (don’t require a high threshold to be activated → activated more easily)


Both increase total Ca2+ influx and lead to increased neurotransmitter release


14
New cards

What are the environmental risk factors of migraines?


<p></p>
15
New cards

What causes pain during a migraine? 🟠

  • Activation of pain-sensitive nerve fibers surrounding blood vessels in the meninges

  • These nerves release signaling molecules (e.g., CGRP), contributing to vasodilation (dilation of blood vessels) and increased pain signaling

  • Activation and sensitization of the trigeminovascular pathway produce migraine pain


<ul><li><p>Activation of pain-sensitive nerve fibers surrounding blood vessels in the meninges </p></li><li><p>These nerves release signaling molecules (e.g., CGRP), contributing to vasodilation (dilation of blood vessels) and increased pain signaling</p></li><li><p>Activation and sensitization of the trigeminovascular pathway produce migraine pain</p></li></ul><p></p>
16
New cards

How does activation of the trigeminovascular system (TGVS) contribute to migraine pain? 🟠

  1. TGVS activation: Trigeminal sensory fibers innervating the meninges and intracranial blood vessels become activated

  2. Neuropeptide release: Activated fibers release CGRP

  3. CGRP effects:

  • Binds receptors on meningeal blood vessels → vasodilation

  • Acts on pain pathways → increased nociceptive signaling and sensitization

  1. Result: Migraine headache pain


17
New cards

What are the four non-pharmaceutical treatments of migraines?

  • Napping or resting with eyes closed in a quiet, darkened room

  • Placing a cool cloth or ice pack on the forehead

  • Drinking lots of fluid, particularly if the migraine is accompanied by vomiting

  • Caffeine


18
New cards

What are the pharmaceutical treatments of migraines?

  • Preventive

    • Erenumab (Aimovig)

    • Monoclonal antibody against CGRP binding site in the CGRP receptor

    • Prevents ligand binding and blocks activation of this receptor

    • Prevents vasodilation of blood vessels


19
New cards

What are the acute treatments of migraines?

  • Ergot derivatives: alpha-adrenergic receptor agonist, serotonin receptor agonist (ergotamine, dihydroergotamine), vasoconstrictor

  • Triptans: Serotonin receptor agonist (sumatriptan), vasoconstrictors, block pain signals

  • Lasmiditan (Reyvow): Serotonin receptor agonist, inhibits neuronal firing and transmission of pain signal

  • Ubrogepant (Ubrelvy): CGRP receptor antagonist, inhibits vasodilation, as well as transmission of pain signal

  • Non-prescription analgesics: Ibuprofen, aspirin, acetaminophen

  • Combination analgesics and caffeine: caffeine is a vasoconstrictor

    • Excedrin: aspirin, acetaminophen, and caffeine

  • Prescription NSAIDs (naproxen, Aleve)

  • Nausea relief (ondansetron, Zofran)

  • Narcotics


20
New cards

What is the behavioral state system, and what are the four diffuse modulatory systems?

  • Behavioral state neurons:

    • Located in the reticular formation of the brainstem, hypothalamus, and limbic system

    • Modulates sensory and cognitive processes, sleep/wake cycles, attention, arousal, modulation of muscle tone, and the ability to focus

  • Diffuse modulatory systems:

    • Originate in reticular formation in brainstem

    • Project axons to large areas of the brain

      • Noradrenergic (NE): Attention, arousal

      • Serotonergic: Mood, sleep, pain

      • Dopaminergic: Movement, reward

      • Cholinergic: Attention, learning, memory


21
New cards

What are psychiatric disorders defined by American Psychiatric Association (2013)?

  • There are significant disturbances in thoughts, feelings, and behaviors

  • These disturbances reflect some kind of biological, psychological, or developmental dysfunction

  • The disturbances lead to significant distress or disability in one’s life

  • The disturbances do not reflect expected or culturally approved responses to certain events

    • Basically u react to the stress in a certain way that isn’t culturally approved (like u could become aggressive)


22
New cards

What are 5 main psychiatric disorders?

  • Anxiety disorders

    • Panic disorder

    • Generalized Anxiety Disorder

  • Depressive disorders

    • Major Depressive Disorder

  • Bipolar disorders

  • Schizophrenia

  • Substance abuse disorders


23
New cards

What are the symptoms, comorbidities, and genetic risks of Major Depressive Disorder (unipolar)

  • Symptoms: Depressed mood/self-esteem, low energy, anhedonia (decreased sensitivity to pleasure), feelings of worthlessness, changes in sleep or appetite, difficulty concentrating, or suicidal ideation

    • Persist daily for 2 weeks or longer

    • Affect other aspects of life

  • Comorbidities: Often associated with another medical diagnosis or psychiatric condition

  • Genetic risk: Multiple common genetic variants contribute to risk


24
New cards

What is the monoamine depletion hypothesis of MDD, and what evidence historically supported it? [COME BACK TO THIS]

  • Proposes that decreased monoamine signaling (5HT = serotonin, NE, DA) contributes to depression

  • Evidence: Proposed when 20% of people taking reserpine for hypertension became depressed

  • Supported by observed side effects of MAOIs, imipramine, desipramine → improve mood and relieve depression

    • Drugs that reduce breakdown by inhibiting MAO or block reuptake increase monoamine availability

  • Lower levels of serotonin metabolites in CSF of people with MDD

  • Diets low in tryptophan can cause symptoms to return bc tryptophan is needed to make serotonin

  • Many drugs that treat MDD act to increase serotonin signaling and/or availability


25
New cards

Why is the monoamine depletion hypothesis insufficient to fully explain MDD?

  • The level of serotonin is less important than how it acts at the synapse, suggesting roles for neuroplasticity in MDD (can’t increase the amount of serotonin to increase effect bc there’s no point if it doesn’t act at the synapse; synaptic components are more important)

    • Pre-synaptic receptors affect synthesis → important

    • Expression and localization of postsynaptic receptors affect response to serotonin →

  • Large placebo effect and spontaneous remission

    • Makes the med ambiguous (no concrete results)


26
New cards

What are the treatments of MDD? [COME BACK TO THIS]

  • MAOIs: Monoamine oxidase inhibitors

    • Reduces breakdown/metabolism of monoamines

  • Reuptake inhibitors

    • Block reuptake of monoamines from the synaptic cleft

    • SSRIs: 5HT (serotonin)

    • SNRIs: 5HT and NE

    • NDRIs: NE and DA

  • Ketamines


27
New cards

Describe the MOA of ketamines

  • GABAergic inhibitory interneuron: Releases GABA, which inhibits other neurons

  • Glutamatergic presynaptic neuron: Releases glutamate, an excitatory neurotransmitter

  • Postsynaptic neuron: Receives glutamate and responds to it


Normally:

  1. Glutamate activates NMDAR on GABAergic interneuron

  2. Influx of ions causes release of GABA

  3. GABA binds to GABA(A) receptor on Glutamatergic presynaptic neuron

  4. Results in Cl- influx (bc its inhibitory)

  5. Cl- influx inhibits the release of glutamate (bad bc we need monoamines to treat depression, less monoamines means less excitabilty)


  • NMDA receptor antagonists → NMDAR is on the postsynaptic cell

    • Glutamate binds to NMDAR to activate it. When NMDAR is active, it allows Cl- to pass through the GABA receptor, which inhibits the exocytosis of monoamines b/c GABA is an inhibitory neurotransmitter

    • But we need monoamines to help with depression so… inhibit NMDAR to stop GABA receptors from working


Ketamine MOA:

  • Prevents glutamate from binding to NMDAR on GABAergic interneuron and glutamatergic presynaptic neuron

  • That means that the GABAergic interneuron can’t release GABA and promote the inhibitory action in the Glutamatergic presynaptic neuron

  • Which means that glutamate is released and then it binds to AMPAR



28
New cards

What are anxiety disorders? Examples?

  • Excessive and persistent fear and anxiety, accompanied by related disturbances in behavior

  • Not all anxiety is an anxiety disorder

  • Often comorbid with other psychiatric disorders

  • EX:

    • Panic disorder

    • Generalized anxiety disorder

    • Social anxiety

    • Specific phobias

    • PTSD


29
New cards

What is the epidemiology of anxiety disorders?

  • Most frequently occurring type of psychiatric disorder

  • 25-30% of US population meets criteria for at least one anxiety disorder during their lifetime

  • More common in women


30
New cards

What is a panic disorder?

  • Recurrent (more than one) and unexpected panic attacks, along with at least one month of persistent concern about additional panic attacks, worry over the consequences of the attacks, or self-defeating changes in behavior related to the attacks

  • Not the result of physiological effects of drugs and other substances, a medical condition, or another mental disorder


31
New cards

What is a panic attack and what are the symptoms?

  • Panic Attack: A period of extreme fear or discomfort that develops abruptly and reaches a peak within 10 mins

    • Accelerated heart rate, sweating, trembling, choking sensations, hot flashes or chills, dizziness or lightheadness, fears of losing control or going crazy, and fears of dying

  • “Fear of fear”


32
New cards

What is generalized anxiety disorder?

  • A relatively continuous state of excessive, uncontrollable, and pointless worry and apprehension; a constant state of feeling overwhelmed, accompanied by fear and worry

  • Not part of another disorder

  • Occurs more days than not for at least 6 months

  • Accompanied by any three of the following symptoms: Restlessness, difficulty concentrating, fatigue, muscle tension, irritability, and sleep difficulties


33
New cards

What are the mechanisms of anxiety disorders?

  • Genetic risk: Multiple common genetic variants contribute to risk

  • Abnormal activity of NE in the locus coeruleus (brainstem nucleus)

  • Inappropriate activation of fight or flight response


<ul><li><p><strong>Genetic risk: </strong>Multiple common genetic variants contribute to risk</p></li><li><p>Abnormal activity of NE in the locus coeruleus (brainstem nucleus)</p></li><li><p>Inappropriate activation of fight or flight response </p></li></ul><p></p>
34
New cards

What are the receptors NE and ACh act on?

  • NE: alpha and beta adrenergic in sympathetic divison

  • Acetylcholine: Nicotinic and muscarinic cholinergic (in presynaptic and post synaptic)


35
New cards

What are the 4 treatments of anxiety disorders?

  • Benzodiazepines:

    • GABA(A) receptor agonist

  • Beta blockers: Propranolol

    • Competitive antagonists for EPI and NE on adrenergic beta receptors of the sympathetic nervous system

  • Anti-anxiety: Buspirone (Buspar)

    • Serotonin receptor 1A agonist

  • Antidepressants: Many SSRIs and SNRIs can also treat anxiety disorders

    • Selective serotonin reuptake inhibitors (SSRI)

    • Serotonin and norepinephrine reuptake inhibitor (SNRI)


36
New cards

Describe how normal serotonin signaling occurs.

  1. Tryptophan is used to synthesize serotonin

  2. Serotonin is then packaged into vesicles in the presynaptic neuron

  3. Serotonin is released into the synaptic cleft

  4. Serotonin binds to postsynaptic receptors to produce a response

  5. Excess serotonin is taking back into the presynaptic neuron by the serotonin transporter (SERT)


There's also an important receptor on the presynaptic neuron: the 5-HT₁A autoreceptor.

When serotonin activates this autoreceptor, it provides negative feedback, reducing further serotonin release.


37
New cards

Describe the MOA of Buspirone

Presynaptic Action:

  • Buspirone binds to 5-HT1A receptors

  • Activating these receptors initially inhibits serotonin neuron firing and serotonin release

  • With repeated administration of buspirone, these autoreceptors gradually become desensitized, reducing their inhibitory effects


Postsynaptic Action:

  • Buspirone also binds to postsynaptic 5-HT1A receptors

  • Actives these inhibitory receptors

  • Decreases postsynaptic neuronal excitability

  • Modulation of neuronal activity contributes to reduced anxiety